MeSH D018223 - dermatofibrosarcoma
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Accord Healthcare | Imatinib | Imatinib Accord |  | 2013-06-30 |  |  |
| Allergan | Imatinib | Imatinib Actavis |  | 2013-04-17 |  |  |
| Amneal Pharmaceuticals | Imatinib | Imatinib |  | 2019-02-08 |  |  |
| Apotex | Imatinib | Imatinib |  | 2016-08-05 |  |  |
| Chartwell Pharmaceuticals | Imatinib | Imatinib |  | 2019-01-17 |  |  |
| CSPC Ouyi Pharmaceutical | Imatinib | Imatinib |  | 2025-04-21 |  |  |
| Dr Reddys Laboratories | Imatinib | Imatinib |  | 2018-08-13 |  |  |
| Eugia Pharma Specialties | Imatinib | Imatinib |  | 2020-07-23 |  |  |
| Hetero | Imatinib | Imatinib |  | 2025-04-14 |  |  |
| Hikma Pharmaceuticals | Imatinib | Imatinib |  | 2018-07-13 |  |  |
1
2
3
>
Clinical Trials
Historical Success Rate
Phase 1
100%4/4
Phase 2
0%0/5
Phase 3
40%2/5
Approved: 2Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use